RETRACTED ARTICLE: The epidemiology and chemotherapeutic approaches to the control
of urinary schistosomiasis in school-age children (SAC): a systematic
review
Human schistosomiases are acute and chronic infectious diseases of
poverty. Currently, epidemiological data of urinary schistosomiasis (US) in
school-age children (SAC) and adults are often reported together making it
difficult to ascertain the true status of the disease. Based on this premise, we
set out to carry out this review.
Method
To achieve this aim, we carried out a computer-aided search of
PubMed, Web of Science, Science Direct, African Journals OnLine (AJOL) and the
database of World Health Organization. However, the information obtained from
these sources was supplemented with additional literatures from Mendeley,
Research Gate, and Google.
Results
The search yielded 183 literatures of which 93 full text research,
review and online articles were deemed fit for inclusion. Our key findings
showed that: (1) of all World Health Organization (WHO) Regions, Africa is the
most endemic zone for US, with Kenya and Senegal recording the highest
prevalence and mean intensity respectively; (2) SAC within the range of
5–16 years contribute most significantly to the transmission cycle of US
globally; (3) gender is a factor to watch out for, with male often recording the
highest prevalence and intensity of infection; (4) contact with open,
potentially infested water sources contribute significantly to transmission; (5)
parental factors (occupation and education status) predispose SAC to US; (6)
economic vis a vis ecological factors play a
key role in infection transmission; and (7) in the last decade, a treatment
coverage of 45% was never achieved globally for SAC or non-SAC treatment
category for urinary schistosomiasis.
Conclusion
In view of the WHO strategic plan to eliminate schistosomiasis by
2020 and the findings from this review, it is obvious that this goal, in the
face of realities, might not be achieved. It is imperative that annual control
programmes be scaled up marginally, particularly in the African region of WHO.
While US-based researches should be sponsored at the grass-root level to unveil
hidden endemic foci, adequate facilities for Water, Sanitation, and Hygiene
(WASH) should be put in place in all schools globally.
Hinweise
The authors have retracted this article because of methodological inaccuracies and incorrect use of the PRISMA/PROSPERO guidelines of systematic reviews and meta-analyses in the article. A re-examination of the data suggests that the authors' conclusions are based on a small subset of available literature. All authors agree with this retraction.
Human schistosomiases are acute and chronic infectious diseases
associated with abject poverty in 78 low and middle-income countries in the
sub-tropical and tropical parts of the world where there is negligible access to
potable water and adequate sanitation. The agents of etiology of these diseases are
“blood-thirsty” digenetic trematodes in the genus Schistosoma [1,
2].
Freshwater gastropod snails in the genus Bulinus are suitable intermediate hosts to Schistosoma haematobium which causes urinary schistosomiasis. The
transmission gap of the disease is bridged when people come into contact with
unwholesome water sources [3‐5] infested with
the cercariae (infective larval form) which mechanically penetrates the skin of
their human definitive hosts. A transmission cycle is consolidated when infected
humans, due to lack of modern waste disposal facilities, indiscriminately pass
urine-infested eggs in close proximity to water bodies where they hatch into larval
form (called miracidia) which infect Bulinus. In
humans, cercariae undergo series of larval migration before maturing into adults
which migrate to the veins of the urinary tract where gravid females lay a large
number of eggs which are responsible for the various signs, symptoms and morbidity
associated with the disease. The classical sign of urinary schistosomiasis is
haematuria, a term coined to describe the presence of blood in urine. Genital
schistosomiais causes pathological damage in both sexes, with females being more at
risk of contracting Human Immuno-Deficiency Virus (HIV) [6, 7].
Anzeige
Nonetheless, a review of the burden of schistosomiasis has shown that
over 200, 000 people die from the complications due to the disease in Sub-Saharan
Africa (SSA) annually while children suffer anaemia, stunted growth [8, 9], urinary tract damage [10] and reduced mental ability to cope with academics. In
advanced cases, hydronephrosis, [11]
ureteral and bladder fibrosis/cancer commonly occur [6].
As a follow up to the 2001 World Health Assembly resolution WHA54.19,
many endemic countries in Africa launched national control programmes largely based
on preventive chemotherapeutic intervention with praziquantel (PZQ) targeting at
least 75% of school-age children-SAC (5─14 years old) and adults at risk of
schistosomiasis [12, 13] by 2010. This resolution aligns properly
with earlier report that SAC, adolescent and young adults usually recorded the
highest prevalence and intensities of schistosomiasis [14]. Meanwhile, the guideline of World Health
Organization required that treatment of SAC (enrolled and not enrolled) be done:
once every year for high-risk communities, once every two years for moderate-risk
communities and twice during their Primary School Age in low-risk communities
[13, 15].
Currently, epidemiological data on prevalence, intensity and control of
US in SAC and adults are often reported together, thus making information peculiar
to SAC to be insufficient in the literature. The implication of this is that it is
difficult to ascertain the epidemiological status of the disease in this group to
enhance the success of control programmes targeting this group. Based on this
premise, the aim of this review article was to study the epidemiology and
chemotherapeutic strategies to the control of US in SAC.
Methods
Search strategy
We carried out a computer-aided search of PubMed, Web of Science,
Science Direct, African Journals OnLine (AJOL) and the database of World Health
Organization (WHO). However, the information obtained from these sources was
supplemented with additional literatures from Mendeley, Research Gate, and
Google. The searches were performed independently by the authors using the key
words: “urinary/urinary schistosomiasis” in combination with “prevalence”,
“intensity”, “morbidity”, “control/praziquantel”, “school” and
“children”.
Anzeige
Selection criteria
Literatures that address prevalence, intensity, morbidity,
indicators or risk factors as well as the control of US, without restriction to
year of publication, were included in this review article. Besides, such papers
addressed school children specifically. The implication of this is that articles
exclusively addressing intestinal schistosomiasis or other Neglected Tropical
Diseases were not considered eligible for inclusion.
Analysis and presentation of data
The secondary data presented in this manuscript were manually
extracted from the articles included in this review paper. Data imported into
Microsoft Excel Spreadsheet were used to generate Bar Charts.
Results
The search
The search yielded 183 literatures. After proper scrutiny of the
retrieved literatures, 93 full text research, review and online articles were
deemed fit for inclusion. Consequently, this review is a product of the findings
from these articles. The flow chart in Fig. 1 shows the result of our search.
×
Characteristics of the included articles
Of the 93 literatures included in this review, majority, 46
(49.46%), were products of researches/reviews carried out in African WHO Region,
with Nigeria recording the second largest number of articles, 19 (20.43%).
Switzerland in European Region, however, accounted for the largest, 22 (23.66%),
which were all technical reports/review articles (see Table 1).
Table 1
Descriptive statistics (estimates) of the features of
the articles included in the systematic review
Variable
Category A
Category B (who region)
Number of articles
%
Countries
Nigeria
Africa
19
20.43
Cameroon
Africa
3
3.23
Cote d’Ivoire
Africa
1
1.08
Mali
Africa
1
1.08
Kenya
Africa
8
8.60
Senegal
Africa
4
4.30
United State of America
The Americas
3
3.23
South Africa
Africa
2
2.15
Switzerland
Europe
22
23.66
Netherlands
Europe
1
1.08
Swaziland
Africa
1
1.08
United Kingdom
Europe
3
3.23
Yemen
Eastern Mediterranean
1
1.08
Malawi
Africa
1
1.08
Niger
Africa
1
1.08
Ghana
Africa
1
1.08
Burkina Faso
Africa
1
1.08
Zimbabwe
Africa
1
1.08
Zambia
Africa
1
1.08
Angola
Africa
1
1.08
Tanzania
Africa
1
1.08
Ethiopia
Africa
2
2.15
Others
14
15.05
Type of Article
Research
61
65.59
Review
6
6.45
Technical report
22
23.66
Online article
4
4.30
*Sample year
1984─1993
4
6.56
1994─2003
4
6.56
2004─2017
44
72.13
Not reported
9
14.75
*Sampling method
Cluster
2
3.28
Random
19
31.15
Universal/census
4
6.56
Stratified
2
3.28
Not reported
33
54.09
Fish bowl/ systematic
1
1.64
*Study type
Cross-sectional
40
65.58
Longitudinal
5
8.19
Not reported
16
26.23
*Sample size determination
Yes
11
18.03
Not reported
30
49.18
Could not be ascertained
20
32.78
*Setting
School
39
63.93
Community
9
14.75
Others
13
21.31
*Population area
Rural
37
60.66
Peri-urban
7
11.48
Others
17
27.87
**Mode of diagnosis
Microscope only
18
43.90
Real time PCR Assays + Reagent strip + Test for
cSEA + microscopy
1
2.44
Reagent strip only
1
2.44
Microscopy and Reagent strip
21
51.22
**Format of intensity
Arithmetic mean only
5
12.19
Geometric mean only
3
7.32
WHO categories only
13
31.71
Geometric+ WHO categories
1
2.44
Not reported/Not specified
19
46.34
*Only applicable to research articles; **Only applicable to
prevalence/ intensity studies on humans; cSEA, Circulating Soluble
Egg Antigen
The sampling years reported by the 61 research articles included in
this review ranged from 1984 to 2017, with the studies executed between 2004 and
2017 being 11 times more in number than those carried out in each of 1984–1993
and 1994–2003. Sixty-Five point Fifty-Eight percent (40), 63.93% (39), and
60.66% (37) of the studies were cross-sectional in nature, carried out in school
settings and rural areas respectively (see Table 1).
However, it is worthy of note that sample size determination,
sampling method, and intensity of US were not reported by 49.18% (30), 54.09%
(33) and 46.34% (19) of the studies included in this review (see Table
1).
Prevalence and intensity of urinary schistosomiasis
Data on the prevalence of US in different endemic settings are
presented in Table 2 below. In Nigeria, the
prevalent rates obtained from 14 research articles with a total sample size of 5675
ranged from 2.07%–78.43%. They showed that 2116 school children were infected,
giving an overall prevalence rate of 37.29%. Coincidentally, these articles
represent the six (6) geopolitical zones of Nigeria.
Table 2
Urine Processing Technique, Prevalence, and intensity of
urinary schistosomiasis by country’s subarea
*Geometric Mean Intensity; N. R, Not reported; **Arithmetic Mean
Intensity; † Not clearly defined
However, six studies from Kenya reported that of the 25, 809
respondents sampled, 11,728 were infected with the infective stage of S. haematobium, giving a prevalence rate of 45.44%. The
prevalence of US obtained from Kenya-based literatures ranged from 8.90%–94%.
Anzeige
Moreover, two Ethiopia-based research articles retrieved showed that of
the 100,030 respondents examined, 310 tested positive for US, resulting in a
prevalence rate of 0.31%.
In Cameroon, out of the 1346 school children interviewed and examined
as reported by two articles, 446 were found to be suffering from the menace of US,
giving a prevalence rate of 33.14%.
Furthermore, a prevalence of 67.16% was computed from a total sample
size of 539 reported by two papers which showed that 362 school children were
infected.
Finally, each research paper obtained from Malawi, Niger, Ghana,
Burkina Faso, Yemen, Zimbabwe, Zambia and Angola reported prevalence rates (sample
size) of: 14.20% (1642), 75.40% (1642), 50% (100), 8.76% (3514), 23.80% (400), 60%
(551), 9.60% (2040) and 61.80% (785) respectively.
Anzeige
Table 2 also presents the
extracted data on the intensity of US. It is obvious that only 17 research articles
(48.57%) reported the intensity of infection due to the disease in question. Of this
figure, 12 (70.59%) presented mean intensity of infection as Arithmetic Mean while
only 5 (29.41%) presented it as Geometric Mean.
By Arithmetic format of reporting mean intensity, the highest value,
154.7 eggs per 10 ml of urine sample, was reported in a survey carried out in Magba
Region, Cameroon while the runner up value, 107.30 eggs per 10 ml of urine sample,
was reported from Kano State, Nigeria. The overall highest mean intensity of
infection was reported in Fatick Region, Senegal as a Geometric Mean Intensity of
356.1 eggs per 10 ml of urine sample. The same location recorded the second highest
mean egg count of 185 eggs per 10 ml of urine sample.
As it stands, Kenya has the highest prevalence while Senegal has the
highest mean intensity of infection with US among SAC.
Of the 41 research articles included in this review paper, 35 reported
a total number of 144,755 participants with prevalence/intensity records. As far asS. haematobium egg concentration technique
was concerned, 11, 18 and 4 articles recorded centrifugation, filtration, and
sedimentation as means of preparing sample for viewing under the microscope.
However, 2 articles from Angola and Zimbabwe did not report technique of egg
concentration.
Anzeige
Risk factors of urinary schistosomiasis in school children
Table 3 presents the factors
that are considered pertinent to the transmission of US in school children. Findings
from this review reveal that SAC within the range of 5–16 years of age were
consistently and unanimously reported as the group with the highest prevalence and
association with US.
Table 3
Risk factors of urinary schistosomiasis peculiar to school
children
By the findings in this review paper, gender played a significant role
in the transmission of US, with males recording higher prevalence of infection and
significant association more often over their female counterparts.
Water-related factors like swimming, playing in shallow waters,
fetching water for domestic uses in open and potentially infested water bodies like
lakes, rivers, ponds, streams, etc. vis a vis
proximity of residence to sources of unwholesome water sources have all been
reported by researchers as key factors in the transmission of the disease.
In addition, parental factors such as educational and occupational
status have been reported by researchers from various endemic settings of US.
Finally, economic and ecological factors like lack of sewage disposal
facilities and climate change were reported as determinant factors of the
disease.
Pathology and morbidity markers of urinary schistosomiasis
Table 4 presents the
pathological consequences and morbidity markers of US by infection phases as
reported by the research articles included in this review.
Table 4
Reported morbidities by infection phases of urinary
schistosomiasis
Morbidity markers identified include swimmer’s itch, eosinophilia,
terminal haematuria, proteinuria, and dysuria. On a broad note, the
morbidities/pathological consequences reported obviously revolve around the
urogenital system as shown in Table 4 below.
They are majorly associated with the chronic phase of the disease.
Table 5 presents a list of
drugs of intervention for US. It shows PZQ as having the highest cure rate and
Niridazole as the least.
Table 5
Mode of administration, dosage and cure rate of selected
drugs for adult S. haematobium
control
Generally, the global population treated for schistosomiasis increased
from 2008 to 2016 with the exception of 2011 and 2013 when a decline was experienced
(Fig. 2). The same applied to the number
of SAC treated as well as their treatment coverage within the same period. The
highest distribution coverage for PZQ was achieved in 2016 (see Fig. 3). However, the SAC requiring chemotherapeutic
intervention with PZQ kept increasing till 2014 (see Table 6 and Fig. 2).
Table 6
Proportion of school-age children requiring treatment and
the number treated for schistosomiasis in the past
decade
**Data not available yet; SAC
School-age Children, NR Not reported,NA Not applicable
×
×
Discussion
Results summary
In summary, the overall findings in this review showed that: (1) of
all WHO Regions, Africa is the most endemic zone for US, with Kenya and Senegal
recording the highest prevalence and mean intensity respectively; (2) SAC within
the range of 5–16 years contribute most significantly to the transmission cycle
of the disease globally; (3) gender is a factor to watch out for, with male
often recording the highest prevalence and intensity of infection; (4) contact
with open, potentially infested water sources contribute significantly to its
transmission; (5) parental factors (occupation and education status) predispose
SAC to US; (6) economic vis a vis ecological
factors play a key role in infection transmission; and (7) in the last decade, a
treatment coverage of 45% was never achieved globally for SAC or non-SAC
treatment category for US.
The need to treat school-age children (SAC)
Meanwhile, schistosomiasis, an infectious disease of poverty, is
easily contracted through poor hygiene and play habits of school children. In
majority of areas endemic for US, a peak of morbidity is usually observed in
school children within age range 7–14 years [16]. On the long run, it prolongs squalor and as a result,
blocks cognitive academic performance and normal growth of children. This
culminates in suffering and sometimes, death [17]. The extent of morbidity due to US is strongly linked
with the intensity and the length of infection period. Because US is more
prevalent in SAC, control programme is directed at them so that the duration of
heavy infection intensity could be reduced markedly [18, 19].
Unfortunately, as our findings revealed, majority of SAC are from
Africa which had previously been reported to have accounted for an estimate of
over 85% of all cases of schistosomiasis globally [20]. Therefore, promoting the health of SAC
has been an integral part of the programme of WHO, United Nations Educational,
Scientific and Cultural Organization (UNESCO), United Nations Children’s Fund
(UNICEF), and other international agencies since the 1950s [21]. SAC are a target group for Mass Drug
Administration (MDA) since WHO expert committee on schistosomiasis met for the
first time 64 years ago [18,
22].
This is ascertained by the projected budget of about USD 116
million for 2009 to 2013 global procurement and delivery of drug to endemic
countries by WHO and the UN systems without custom fees and clearance charges
due to existing agreements [23,
24]. In Central Nigeria, study
on the epidemiology of US in SAC using the WHO paradigm of ≥50% prevalence has
been used as a benchmark for the treatment of the disease in adults
[25].
Management strategies of urinary schistosomiasis in SAC and associated
challenges
Various strategies have been applied in the control of US. These
include indiscriminate mass treatment, active case finding and treatment of
particular risk groups such as school-aged children [26]. However, before the advent of PZQ,
other drugs effective against different species and stages of development were
used (see Table 5). Drugs of
intervention for schistosomiasis progressed from antimonial compounds to PZQ
which is the drug of choice today [27]. Metrifonate and Hycathone mesylate are effective for the
treatment of US. Lucanthone hydrochloride was used from 1948 to mid-sixties.
When given a short treatment from 3 to 6 days, it had moderate activity againstS. haematobium. Niridazole is used
against S. mansoni, S. japonicum andS. haematobium [28].
Corticosteroids and anticonvulsants are used to treat katayama fever in order to
suppress the hypersensitivity reaction and with PZQ to eliminate the already
mature adult. PZQ should be administered with great caution in the case or
concurrent neurocysticercosis [29].
The use of Artemisinin derivatives as prophylaxis for acute schistosomiasis,
possibly in combination with PZQ, has been investigated. However, Artemisinin
use in malaria-endemic areas is not encouraged because of anticipated drug
resistance [30].
However, the most rapid and cost-effective way to control morbidity
due to schistosomiasis is through a chemotherapeutic intervention with PZQ
[31]. PZQ and Albendazole can,
however, be administered together safely where there is co-endemicity of
schistosomiasis and Soil-Transmitted Helminthiasis (STH) [32]. It is already well known that after
chemotherapy, cessation of symptoms is evidenced in the reduction of egg
excretion, proteinuria, haematuria, urinary iron loss, leucocyturia, and few
remaining schistosomes which cannot multiply [17, 18,
33‐36].
Consequently, they pose little or no threat to their hosts. Therefore, control
programmes should focus on the achievement of a sharp decline in the intensity
of infection [17]. Based on this
premise, in 2001, the World Health Assembly adopted resolution 54.19 which set a
target for all endemic countries to regularly treat over 75% of all SAC at risk
of morbidity due to schistosomiasis and STH by 2010 [37, 38]. It is pertinent to state that the result of this review
clearly showed that this aim was not achieved (see Table 6).
Nevertheless, the greatest challenge of MDA is to extend regular
drug coverage to reach all the children at risk of morbidity due to infection by
helminths [23]. There are two
perspectives to this. One, each School-age Child (SAC) treated may not have
access to enough PZQ that would clear all the parasites. Two, the distribution
coverage may not cater for the whole population of infected SAC. Consequently,
symptoms of chronic infection may show up after 5–15 years in children who were
partially treated as a result of poor coverage of PZQ [20]. However, the report of a School-Based
Treatment carried out in Zanzibar Island, Tanzania, where 8000 pupils were
treated showed amazing coverage of 85.2 and 86.9% in Pemba and Unguja Districts
respectively [39].
PZQ is not without its adverse reactions like abdominal pain,
dizziness, headache, vomiting, diarrhea, round, swollen and itching skin rashes,
and fever [40]. These are usually
mild and last for 24 h. These are reactions from dying worms.
In addition, studies have shown that false negative results cause
infected SAC to escape treatment, leading to chronic condition and if such case
occurs after MDA, cure rate may be overestimated and this may be a prelude to
drug resistance and further transmission of US [41].
It is hoped that in the nearest future, global schistosomiasis
control programmes will receive a boost when the current “evolutionary” process
of vaccine-linked chemotherapy culminates in approval by WHO. A good number of
these vaccines undergoing preclinical and clinical trials on the field are
particularly made for children [42].
Limitations of the review
This review took articles reported in English into consideration
instead of including those reported in other languages. Besides, we noticed that
mean intensity of infection with US was either underreported or not reported by
some authors of articles included in this review article. Consequently, the
report of the mean intensity reported here may not be an accurate reflection of
what is obtainable among SAC globally.
Conclusion
The prevalence rates and intensities of US vis
a vis its impact on SAC, keep increasing from year to year, leading
to increase in the global population requiring chemotherapeutic intervention with
PZQ. In view of the WHO strategic ambitious plan to eliminate schistosomiasis by
2020 [43] and the findings from this
review stipulating that in the last decade, a PZQ distribution coverage of 45% has
never been achieved for SAC, it is obvious that this goal, in the face of realities,
might not be achieved just like the strategic plan for 2010. Our view is in
agreement with the report that if WHO sustains the current treatment trend,
elimination is achievable in 2030 [44].
It is imperative that annual control programmes be scaled up marginally,
particularly in the African region of the WHO. While US-based researches should be
sponsored at the grass-root level to unveil hidden endemic foci, adequate facilities
for Water, Sanitation, and Hygiene (WASH) should be put in place in all schools
globally.
Acknowledgements
We express our profound gratitude to the authors of the research papers,
review articles and online materials used in the course of preparing the manuscript
of this review article. Without their meritorious contribution to knowledge about
schistosomiasis, this paper would have been written with scanty
references.
Funding
Not applicable.
Availability of data and materials
Not applicable.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional
claims in published maps and institutional affiliations.
Open Access This article is distributed
under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction
in any medium, provided you give appropriate credit to the original author(s)
and the source, provide a link to the Creative Commons license, and indicate if
changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless
otherwise stated.
RETRACTED ARTICLE: The epidemiology and chemotherapeutic approaches to the control of urinary schistosomiasis in school-age children (SAC): a systematic review